Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
TILE | US
0.36
1.19%
Consumer Cyclical
Textile Manufacturing
30/06/2024
08/06/2026
30.50
30.23
31.05
30.14
Interface Inc. designs produces and sells modular carpet products primarily in the United States and internationally. The company operates in two segments Americas (AMS) and Europe Africa Asia and Australia (EAAA). The company offers modular carpets under the Interface and FLOR brand names; luxury vinyl tiles and vinyl sheet under the Interface brand; carpet tiles under the CQuestGB name for use in commercial interiors include offices healthcare facilities airports educational and other institutions hospitality spaces and retail facilities as well as residential interiors; and modular resilient flooring products. It also provides carpet replacement installation and maintenance services; and rubber flooring under the norament and noraplan brand names. The company produces and sells an adapted version of its carpet tile for the healthcare facilities market. In addition it sells a proprietary antimicrobial chemical compound under the Intersept name; sells TacTiles a carpet tile installation system as well as various adhesives and products; and provides turnkey project management services for global accounts and other customers through its InterfaceSERVICES business. The company sells its products directly to end-users as well as indirectly through independent contractors installers or distributors. Interface Inc. was incorporated in 1973 and is headquartered in Atlanta Georgia.
View LessPositive Momentum
Strength based on increasing price with high volume
Value Stock (Price to Book < 3)
Strong Sharpe Ratio (> 1.2)
Smallcap (300M - 2B USD)
High Market Beta (> 0.8)
High Debt to Equity (> 0.75)
Bullish: Stable Volatility (6-month <= 1-month volatility) is positive for the stock performance.
10 days
21.6%1 month
35.6%3 months
37.7%6 months
32.6%17.81
14.53
2.60
1.06
0.39
9.33
1.22
0.97
171.17M
1.78B
1.78B
0.20
10.72
41.40
5.20
15.83
1.28
1.90
Short-term: Bullish (SMA10D > SMA1M)
Intermediate-term: Bullish (SMA1M > SMA3M)
Long-term: Bullish (SMA6M > SMA12M)
Range10D
2.88
Range1M
4.01
Range3M
6.65
Rel. volume
1.11
Price X volume
19.71M
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
|---|---|---|---|---|---|---|---|
No data | |||||||
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
|---|---|---|---|---|---|---|---|
| Clover Leaf Financial Corp | CLOV | Healthcare Plans | 3.92 | 1.95B | 2.35% | n/a | 1.23% |
| Bausch Health Companies Inc | BHC | Drug Manufacturers-Specialty & Generic | 5.11 | 1.88B | -4.84% | n/a | -1843.40% |
| Perrigo Company plc | PRGO | Drug Manufacturers-Specialty & Generic | 11.61 | 1.58B | 7.20% | n/a | 93.52% |
| Phibro Animal Health Corporation | PAHC | Drug Manufacturers-Specialty & Generic | 31.76 | 1.29B | -2.07% | 401.17 | 204.74% |
| Alvotech Ordinary Shares | ALVO | Drug Manufacturers-Specialty & Generic | 4.24 | 1.28B | 19.77% | n/a | -196.14% |
| Harrow Health Inc | HROW | Drug Manufacturers-Specialty & Generic | 33.1 | 1.17B | -0.27% | n/a | 331.16% |
| Collegium Pharmaceutical Inc | COLL | Drug Manufacturers-Specialty & Generic | 33.27 | 1.07B | -0.33% | 14.45 | 258.31% |
| Karyopharm Therapeutics Inc | KPTI | Drug Manufacturers-Specialty & Generic | 8.5 | 1.06B | -6.39% | n/a | -148.05% |
| Pacira Pharmaceuticals Inc | PCRX | Drug Manufacturers-Specialty & Generic | 22.86 | 1.05B | 0.48% | 13.05 | 73.76% |
| OPKO Health Inc | OPK | Drug Manufacturers-Specialty & Generic | 1.43 | 989.54M | -0.69% | n/a | 19.31% |
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | 9.33 | - | - |
| Ent. to Revenue | 1.22 | - | - |
| PE Ratio | 17.81 | - | - |
| Price to Book | 2.60 | - | - |
| Dividend Yield | 0.20 | - | - |
| Std. Deviation (3M) | 37.68 | - | - |
| Debt to Equity | 1.06 | - | - |
| Debt to Assets | 0.39 | - | - |
| Market Cap | 1.78B | - | - |